Bidan Zheng

Title: Bidan Zheng: Innovator in Anti-Cancer Drug Development

Introduction

Bidan Zheng is a notable inventor based in Guangdong, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer drugs. His innovative work has the potential to impact cancer treatment positively.

Latest Patents

Bidan Zheng holds a patent for a compound titled "Triptolide acrylate, preparation method therefor and use thereof." This invention discloses a new triptolide derivative that exhibits anti-cancer activity. The patent outlines a preparation method for the compound and its medical applications in the formulation of anti-cancer drugs. The triptolide acrylate and its pharmaceutically acceptable salts have shown effectiveness in inhibiting tumor growth in animal models. In vitro experiments have demonstrated that the compound significantly increases the protein expression of p53, promotes apoptosis in tumor cells, and inhibits the growth and metastasis of cancer cells. Importantly, the toxicity of this compound to normal cells is lower than that of triptolide.

Career Highlights

Bidan Zheng has worked at prominent institutions, including the Guangdong Provincial Hospital of Traditional Chinese Medicine and The Second Affiliated Hospital of Guangzhou University of Chinese Medicine. His experience in these organizations has contributed to his expertise in medicinal research and development.

Collaborations

Bidan Zheng has collaborated with notable colleagues, including Bo Liu and Xianzhang Huang. These partnerships have facilitated advancements in his research and the development of innovative solutions in cancer treatment.

Conclusion

Bidan Zheng's contributions to the field of anti-cancer drug development through his innovative patent highlight his role as a significant inventor. His work not only advances medical science but also offers hope for improved cancer therapies.